Search

Search Constraints

You searched for: Author/Creator Yang, Jay

Search Results

13. EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study. Issue 6 (June 2022)

14. First‐in‐human study of JNJ‐63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia. Issue 3 (16th January 2023)